Defining the quality of interdisciplinary care for patients with brain ...
Sep 25, 2024 Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel recommendations. Camilo E Fadul
Download complete digital editions, study guides, and reference documents for Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel recommendations. All files are verified for readability across desktop e-readers, Kindle, tablets, and mobile devices in high-definition digital formats.
Click on any verified title in the search results below. A secure direct download link will be prepared with instant attachment delivery.
Yes, all documents are formatted for full compatibility across Adobe Acrobat, Amazon Kindle, Apple Books, and standard PDF viewers.
Sep 25, 2024 Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel recommendations. Camilo E Fadul
Jun 6, 2026 mented deprescribing recommendations Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel
Jul 13, 2026 In the setting of brain metastases treated treatment in non-small cell lung cancer patients with brain metastasis harboring epidermal
Dec 19, 2025 Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel recommendations. Lancet Oncol. 2024
Feb 26, 2026 Most data are derived from head and neck cancer trials. • Brain46-62: most studies describe the addition of EGFR tyrosine kinase inhibitors (
Defining the quality of interdisciplinary care for patients with brain metastases: modified Delphi panel recommenda- tions. Lancet Oncol. 2024 Sep;25(9
Sep 26, 2025 Radical, high-dose stereotactic RT is also increasingly used in the oligometastatic or oligoprogressive setting or to treat brain metastases. RT
A 10-year literature review of family caregiving for motor neurone disease: Moving from caregiver burden studies to palliative care interventions. Palliative
chemotherapy (capecitabine) in hormonal receptor positive/HER2 negative metastatic breast cancer patients with resistance to aromatase inhibitors. - Phase II
Jan 12, 2024 A practical tool for clinicians, the result of a modified Delphi expert consensus approach. Thomas H. Ottens1,2. , Carsten Hermes , Valerie
Aug 27, 2026 identifying whether a patient Quality of Interdisciplinary Care for Patients with Brain Metastases: Modified Delphi Panel Recommendations
New insights in the treatment of this challenging cancer needs the contribution of many and different experts. BACKGROUND. Merkel cell carcinoma (MCC) is a rare
Mar 1, 2026 Topics include therapy selection in the adjuvant and metastatic settings, considerations for special patient populations, response monitoring
A practical tool for clinicians, the result of a modified Delphi expert consensus approach. Thomas H. Ottens1,2. , Carsten Hermes , Valerie Page3. , Mark
Oct 27, 2026 The panel recommended that each patient with midgut NETs considered for surgical resection be assessed for the presence of carcinoid syndrome
Feb 1, 2026 Preliminary results of whole brain radiotherapy with concurrent trastuzumab for treatment of brain metastases in breast cancer patients. Int
May 14, 2025 Background: Metastatic triple-negative breast cancer (BC; mTNBC) is one of the most aggressive cancers, difficult to treat due to the absence of
Outcomes of stereotactic radiotherapy as first-line local treatment of melanoma patients with brain metastases. Clinical. Digital Poster. Sarcoma/skin cancer
Topics include therapy selection in the adjuvant and metastatic settings, considerations for special patient populations, response monitoring, and patient
Integrated palliative and survivorship care improves patients' quality of life, oncology patients with critical illness: A modified Delphi consensus